Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts


About Conference

With the tremendous success of the previous Emerging Diseases 2019, Barcelona, Spain on December 02-03, 2019, we hereby invite all the participants from all over the globe to attend “11th International Conference on Emerging Infectious Diseases, November 23-24, 2020 Rome, Italy. We invite you to join us at the Emerging Diseases 2020 conference which will cover all the aspects of emerging infectious diseases, where you will be sure to have knowledge with scholars and experts from around the world for the paradigm of the infection diseases and latest research related to the this field. It will be a lifetime opportunity for high quality scientific program with session lectures, keynote talks, symposia, workshops, poster presentations, exhibition and different programs for participants from all across the globe.

Emerging Diseases 2020 is a remarkable conference which brings together the international collaboration of scientists, Researchers, specialists from leading universities and research institutions making the conference a perfect platform to globalize experience, foster collaboration across industry and academia, and evaluate emerging technologies all around the world.

Target Audience:

  • Microbiologists
  • Bacteriologists
  • Virologists
  • Parasitologists
  • Mycologist
  • Pathologists
  • Pharmacists
  • Epidemiologists
  • Health care professionals
  • Research scholars
  • Infectious diseases associates and societies.
  • Laboratory technicians
  • Diagnostics companies
  • Drug manufacturing companies
  • Data management companies
  • Medical colleges
  • Infectious Diseases Researchers

Why to Attend?

Emerging Diseases 2020 is giving a worldwide stage to the researchers who are contributing in the field of emerging infectious diseases. World-eminent speakers, guest of honors, and the most up to date upgrades are particular components of this get-together and with individuals from around the globe concentrated on finding out about uncommon illnesses and its advances; An expanding number of distinguished methods makes it important to complete propelled research here of irresistible sicknesses. Emerging Diseases 2020 provides you the forum to conduct presentations, disseminate data, B2B meetings, meet with potential scientists, trade learning on late improvements and make an unmistakable imprint by invigorating development at this event.

For Scientific Sessions please go through the link:

For Abstract Submission please go through the link:

Market Analysis


This International two day conference will provide practical evidence based strategies to engage your workforce and reduce the spread of acute healthcare associated infections. Emerging Diseases 2020 is to promote the health care perspectives which include plenary speeches, roundtable discussions, symposiums, abstracts, and workshops on Emerging Infectious Diseases and Control risks. The goal is to bring together a multidisciplinary group to identify important issues relating to diseases which is emerging in Russia, Europe, United States, and Asia Pacific, Middle East and other parts of the world. Over 500 scientists, clinicians, nurses, patients, government officials, and representatives from pharmaceutical companies will participate. This summary provides the recommendations from the conference that will be used to develop an action plan against infectious diseases which is lethal to the world. It also comprises of actions proposed by plenary speakers, roundtable faculty and students, conference participants.

Importance and Scope

An emerging infectious diseases meeting puts together various practices which when used appropriately restrict the spread of infection. The awareness is required to prevent the transmission of communicable diseases in all health care settings. The notion of the conference demands a basic understanding of the epidemiology of diseases; the importance of establishing prevention measures and bundles during hospital renovation works to preserve the patient from environment-borne infections. This peer is also imperative for health care administrators to ensure implementation of the infection control program in health care facilities.

It also causes for the significant patient safety issue, and can also be an Occupational Health and Safety issue. A well functioned awareness program helps to minimize the risks for patients. Each health care worker needs to understand their role in public health practice, integrate it into daily activities, and articulate this role to others.

Why Rome, Italy??

Rome is the capital city and a special commune of Italy. Rome also serves as the capital of the Lazio region. With 2,872,800 residents in 1,285 km2, it is also the country's most populated commune. It is the fourth most populous city in the European Union by population within city limits. It is the centre of the Metropolitan City of Rome, which has a population of 4,355,725 residents, thus making it the most populous metropolitan city in Italy. Rome is located in the central-western portion of the Italian Peninsula, within Lazio (Latium), along the shores of the Tiber. The Vatican City is an independent country inside the city boundaries of Rome, the only existing example of a country within a city: for this reason Rome has been often defined as capital of two states.

Members Associated with Emerging Infectious Diseases Research

The mission of the Emerging Diseases 2019 conference in Health Care initiative was to assist in reducing dissemination of infections associated with healthcare, by assisting with the assessment, planning, implementation and evaluation of national infection control policies. The ultimate goal is to endorse quality promotion of health care which is safe for patients, health care workers, others in the health care setting and the environment, in the Infectious Diseases field

Hospitals Associated with Emerging Infectious Diseases Research

Healthcare-associated infections (HAI) are a threat to patient safety. CDC provides national leadership in surveillance, outbreak investigations, laboratory research, and prevention of healthcare-associated infections. CDC uses knowledge gained through these activities to detect infections and develop new strategies to prevent healthcare-associated infections. Public health action by CDC and other healthcare partners has led to improvements in clinical practice, medical procedures, and the ongoing development of evidence-based infection control guidance and prevention successes.

Major Infectious Diseases Research Associations around the Globe:

  • British Infection Association
  • Infectious Disease Society of America
  • Infectious Diseases Research Network
  • European Society for Clinical Microbiology and Infectious Diseases
  • British Society for Antimicrobial Chemotherapy
  • Society for General Microbiology
  • British HIV Association
  • The Hospital Infection Society
  • Infection Prevention Society
  • The Royal Society of Tropical Medicine and Hygiene
  • UK Clinical Virology Network
  • World Health Organization
  • Royal Society for Public Health
  • Health Protection Scotland
  • The Society of Health care Epidemiology of America
  • Centers for Disease Control and Prevention
  • Asia Pacific Society of Infection Control
  • Infection Control Association
  • Infection Prevention & Control - American Nurses Association
  • Infection prevention and Control Canada
  • The Infection Control Nurses Association
  • Infection Control - California Hospital Association
  • Infection Control Association of Zimbabwe
  • International Federation of Infection Control
  • Texas Society of Infection Control & Prevention
  • Philippine Hospital Infection Control Society
  • Healthcare Infection Society
  • Infection Control Association of NSW
  • Major Universities on Infection Prevention Research
  • Anahuac University North Campus, Mexico
  • Australian National University, Australia
  • Benha University, Egypt
  • Birmingham City University, UK
  • Center for Clinical Pharmacology, Belgium
  • Charles Darwin University Casoria Australia
  • Columbia University Medical Center, United States
  • Columbia University, USA
  • Curtin University Bentley, Australia
  • Dar Al Uloom University, Saudi Arabia
  • Duke University, USA
  • Emory University, USA
  • GMEC, The Global Medical Excellence Cluster
  • Guangzhou Medical University, China
  • Guangzhou Medical University, China
  • Harvard University, United States
  • Harvard University, USA
  • Imperial College London, United Kingdom
  • Infection Control University
  • Iqbal Chest Centre, Bangladesh
  • John Hopkins University, USA
  • Johns Hopkins University, United States
  • Karolinska University, Sweden
  • Kindai University, Japan
  • King Saud Bin Abdulaziz University, Saudi Arabia
  • King's College London, UK
  • Kumamoto University, Japan
  • Linnaeus University, Sweden
  • Macquarie University, Australia
  • Mayo Clinic College of Medicine, USA
  • McGill university   Montréal, Canada
  • McMaster University, Canada
  • Medi7 Bentleigh, Australia
  • Murdoch University   Murdoch, Australia
  • National Institutes of Health, USA
  • Newcastle University, Australia
  • Northwestern University, Qatar
  • Osaka University, Japan
  • Oxford University, UK
  • Philip Morris International R&D, Switzerland
  • Pompeu Fabra University, Spain
  • Queen Mary University, UK
  • Radboud University Medical Center, Netherlands
  • Rare Genomics Institute, USA
  • Research Institute of Hospital del Mar, Spain
  • Samsung Medical Center, South Korea
  • St George’s University of London, UK
  • St. George Hospital, Australia
  • Stanford University, USA
  • Tasmanian Health Service, Australia
  • The Chest & Heart Association of Bangladesh, Bangladesh
  • The Fourth Hospital of Harbin Medical University, China
  • The Jikei University School of Medicine, Japan
  • The University of Newcastle, Australia
  • Tufts university, United States
  • United Hospital, Bangladesh
  • University College London, UK
  • University of British Columbia, Canada
  • University of Buffalo, United States
  • University of California Los Angeles, United States
  • University of California, USA
  • University of Cambridge, USA
  • University of Canberra Bruce, Australia
  • University of Celiac Disease Center, USA
  • University of Chicago Medicine, USA
  • University of Colorado, USA
  • University of Groningen, Netherlands
  • University of Lincoln, UK
  • University of London Imperial College Of Science Technology And Medicine, UK
  • University of Maastricht, Netherlands
  • University of Maryland Medical Center, Australia
  • University of Maryland Medical Center, United States
  • University Of Melbourne, Australia
  • University Of Minnesota, United States
  • University of Newcastle, Australia
  • University of Pennsylvania, USA
  • University of Pittsburgh Study
  • University of Pittsburgh, USA
  • University of Queensland, Australia
  • University of Tasmania, Australia
  • University of Toronto, Canada
  • University of Valencia, Spain
  • University of Washington, USA
  • University of Washington, USA
  • University of Zurich, Switzerland
  • University-of-the-sunshine-coast, Australia
  • Weill Cornell Medical College, Qatar
  • Wits University, South Africa
  • Yale University School of Medicine, USA
  • Yonsei University, South Korea
  • Major Companies Associated with Infection Prevention Research
  • Abbott Laboratories, UK
  • Actavis, USA
  • Aegerion Pharmaceuticals, Japan
  • Alexion Pharmaceuticals Inc, Switzerland
  • Almirall, Spain
  • Amgen, USA
  • Amicus Therapeutics, USA
  • Amphastar Pharmaceuticals, Inc
  • Araim Pharmaceuticals
  • Astellas Pharma US
  • AstraZeneca, Switzerland
  • AstraZeneca, UK
  • Baxter International Deerfield
  • Bayer HealthCare, Germany
  • Bayer, Germany
  • Beacon Pharmaceuticals, Bangladesh
  • Biotie Therapies Corp, Finland
  • Bioxyne Limited, Australia
  • Boehringer Ingelheim, Germany
  • Celgene, Switzerland
  • Centrapharm Ltd, UK
  • Chiesi Pharmaceutical, Italy
  • Cohero Health, USA
  • Daiichi Sankyo Europe, Germany
  • Daiichi Sankyo, Japan
  • Dohmen Life Science
  • European Medicines Agency
  • Forest Laboratories, USA
  • Gecko Health, USA
  • Generics (UK) Ltd, UK
  • Genus Oncology Vernon Hills, USA
  • Genzyme, USA
  • Gilead sciences, USA
  • GlaxoSmithKline, UK
  • Global Data, UK
  • Gsk, London
  • Hormosan Pharma, Germany
  • Ikris Pharma Network Pvt Ltd, India
  • Kissei Pharmaceutical Co., Ltd, Japan
  • Kyowa Hakko Kirin Co. Ltd, Japan
  • Lallemand Pharma, Switzerland
  • Marathon Pharmaceuticals
  • Merck & Co, USA
  • Millennium Pharmaceuticals
  • Napp Pharmaceuticals Ltd, UK
  • Novartis, Switzerland
  • NPS Pharmaceuticals
  • Octapharma, USA
  • Onyx Pharmaceuticals, USA
  • Otsuka Holdings Co., Ltd, Japan
  • Panmira Pharmaceuticals, LLC, USA
  • Pearl Therapeutics, Inc
  • Pfizer, USA
  • PharmaMar, USA
  • Prosensa, Netherlands
  • PT Boehringer Ingelheim, Indonesia
  • Queensland Respiratory Laboratory Pty. Ltd, Australia
  • Ranbaxy Laboratories Limited
  • Raptor Therapeutics
  • Roche, Switzerland
  • Sanofi, France
  • Sarepta Therapeutics, USA
  • Sigma-Tau Pharmaceuticals, Italy
  • Sunovion Pharmaceuticals, USA
  • Swedish Orphan Biovitrum AB, Sweden
  • Takeda, Japan
  • TriStem Corp Ltd, UK
  • Vertex Pharmaceuticals, USA
  • ViroPharma
  • ViroPharma, USA
  • Visionary Pharmaceuticals, Inc, USA
  • Yungjin Pharm Ind. Co., Ltd, South Korea

Market Research on Emerging Diseases

The global infectious disease market size was valued at USD 46.88 billion in 2017 and is projected to grow at a CAGR of 6.6% during the forecast period. Rising prevalence of infectious ailments, increasing expenditure to boost the penetration rate of treatments of these diseases, rising initiatives for creating awareness about treatments & diagnosis of these conditions, and increasing clinical trial studies for development of new drugs are likely to be the factors responsible for growth of this market.  In 2016, the HIV segment held the largest share i.e., 45.9% of the market. Increasing prevalence of HIV, rising funding activities for patients suffering from HIV, increasing supply of free HIV self-test kits in African countries, and rising awareness campaigns are the key factors responsible for the largest share held by this segment. In addition, WHO aims to test 90% and treat 80% of the people suffering from HBV and HCV by 2025, through its Global Health Sector Strategy on viral hepatitis, which is further expected to contribute to the growth of this segment.

To Collaborate Scientific Professionals around the World

Conference Date November 23-24, 2020

For Sponsors & Exhibitors

Speaker Opportunity

Supported By

Journal of Infectious Diseases & Therapy Journal of Infectious Diseases and Medicine Journal of Infectious Disease and Pathology Journal of Infectious Diseases and Diagnosis

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by